Drug Trial Radar · NCT06471543
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
108
Actual
Start
Sep 30, 2024
Primary completion
Jun 3, 2026
Study completion Aug 25, 2026
Sponsor
- Lead sponsor
- Ikaria Bioscience Pty LtdIndustry
- Sponsor type
- Industry
- First posted
- Jun 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of single doses of RN0361 in Adult healthy subjects and Adult Hypertriglyceridemic Subjects.
Conditions
- Hypertriglyceridemia
- Familial Chylomicronemia Syndrome
Interventions
RN0361Drug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number and incidence of adverse events (AEs)/serious adverse events (SAEs) possibly or probably related to treatment of RN0361 in adult healthy subjects.Time frame: Up to Day85
- Absolute and percent change from baseline in APOC3 and fasting triglycerides (TG) in subjects with HTGTime frame: Up to Day183
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
TBC Research LLC,
Tamarac, Florida
Versailles Family Medicine / Avacare
Versailles, Kentucky
Axis Clinicals USA
Dilworth, Minnesota
Synergy Groups Medical
Houston, Texas
Tranquil
Webster, Texas
Ogden Clinic, Mountain View / Avacare
Pleasant View, Utah
University of the Sunshine Coast Clinical Trials
Morayfield, Queensland, Australia
University of the Sunshine Coast Clinical Trials, Sippy Downs
Sippy Downs, Queensland, Australia
Altona Clinical Research
Altona N., Victoria, Australia
Nucleus Network Melbourne
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.